BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22502666)

  • 1. Evaluation of DNA repair gene XRCC1 polymorphism in prediction and prognosis of hepatocellular carcinoma risk.
    Li QW; Lu CR; Ye M; Xiao WH; Liang J
    Asian Pac J Cancer Prev; 2012; 13(1):191-4. PubMed ID: 22502666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on the DNA repair gene XRCC1 and XRCC3 polymorphism in prediction and prognosis of hepatocellular carcinoma risk.
    Han X; Xing Q; Li Y; Sun J; Ji H; Huazheng P; Jun L
    Hepatogastroenterology; 2012 Oct; 59(119):2285-9. PubMed ID: 22456434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism of DNA repair gene XRCC1 and hepatocellular carcinoma risk in Chinese population.
    Pan HZ; Liang J; Yu Z; Lun LM; Li H; Wang Q
    Asian Pac J Cancer Prev; 2011; 12(11):2947-50. PubMed ID: 22393969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implication of polymorphisms in DNA repair genes in prognosis of hepatocellular carcinoma.
    Yue AM; Xie ZB; Guo SP; Wei QD; Yang XW
    Asian Pac J Cancer Prev; 2013; 14(1):355-8. PubMed ID: 23534753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An updated meta-analysis on the association of X-ray repair cross complementing group 1 codon 399 polymorphism with hepatocellular carcinoma risk.
    Wang YD; Zhai WL; Wang HY; Xia XQ
    Asian Pac J Cancer Prev; 2014; 15(11):4443-8. PubMed ID: 24969866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis.
    Qi Y; Cui L; Song Y; Li N
    Mol Biol Rep; 2014 Feb; 41(2):879-87. PubMed ID: 24390232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians.
    Natukula K; Jamil K; Pingali UR; Attili VS; Madireddy UR
    Asian Pac J Cancer Prev; 2013; 14(9):5275-9. PubMed ID: 24175813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
    Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
    Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of XPD and XRCC1 genetic polymorphisms with hepatocellular carcinoma risk.
    Guo LY; Jin XP; Niu W; Li XF; Liu BH; Wang YL
    Asian Pac J Cancer Prev; 2012; 13(9):4423-6. PubMed ID: 23167354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Italian population.
    Santonocito C; Scapaticci M; Nedovic B; Annicchiarico EB; Guarino D; Leoncini E; Boccia S; Gasbarrini A; Capoluongo E
    Int J Biol Markers; 2017 May; 32(2):e190-e194. PubMed ID: 28058700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis.
    Li J; Li Z; Feng L; Guo W; Zhang S
    Tumour Biol; 2013 Feb; 34(1):261-9. PubMed ID: 23055199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic polymorphisms in X-ray repair cross-complementing gene 1 and susceptibility to papillary thyroid carcinoma].
    Zhu QX; Bian JC; Shen Q; Jiang F; Tang HW; Zhang HW; Wu Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):702-5. PubMed ID: 15555397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA repair XRCC1 Arg399Gln polymorphism is associated with the risk of development of end-stage renal disease.
    Trabulus S; Guven GS; Altiparmak MR; Batar B; Tun O; Yalin AS; Tunckale A; Guven M
    Mol Biol Rep; 2012 Jun; 39(6):6995-7001. PubMed ID: 22302399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences.
    Letkova L; Matakova T; Musak L; Sarlinova M; Krutakova M; Slovakova P; Kavcova E; Jakusova V; Janickova M; Drgova A; Berzinec P; Halasova E
    Mol Biol Rep; 2013 Sep; 40(9):5261-73. PubMed ID: 23673479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated assessment of the association of the XRCC1 Arg399Gln polymorphism with lung cancer risk in the Chinese population.
    Yang HY; Yang SY; Shao FY; Wang HY; Wang YD
    Asian Pac J Cancer Prev; 2015; 16(2):495-500. PubMed ID: 25684477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XRCC1 Arg399Gln gene polymorphism and the risk of systemic lupus erythematosus in the Polish population.
    Warchoł T; Mostowska A; Lianeri M; Lącki JK; Jagodziński PP
    DNA Cell Biol; 2012 Jan; 31(1):50-6. PubMed ID: 21682595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the XRCC1 Arg399Gln gene polymorphism in the development of cervical carcinoma.
    Roszak A; Lianeri M; Jagodzinski PP
    Int J Biol Markers; 2011; 26(4):216-20. PubMed ID: 21928248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms associated with chronic obstructive pulmonary disease.
    Yang SF; Xu YJ; Xie JG; Zhang ZX
    Chin Med J (Engl); 2009 Apr; 122(8):960-6. PubMed ID: 19493423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
    Xie T; Wang ZG; Zhang JL; Liu H
    World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis.
    Zeng FR; Ling Y; Yang J; Tian XC; Yang X; Luo RC
    Tumour Biol; 2013 Feb; 34(1):555-63. PubMed ID: 23188703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.